Literature DB >> 10554515

[Conditional mutagenesis--second generation knockout mice as models for internal diseases].

J C Brüning1, C R Kahn, W Krone, D Müller-Wieland.   

Abstract

KNOCKOUT MICE: The generation of knockout mice has largely improved our understanding of the function of a variety of gene products. Gene inactivation experiments in mice have yielded numerous animal models for human diseases, thereby expanding our understanding of the underlying pathophysiological mechanisms. The use of conventional knockout experiments is limited if the phenotyp of gene disruption results in embryonic letality. CONDITIONAL MUTAGENESIS: Conditional mutagenesis aims to overcome this limitation by regional and temporal control of gene inactivation in mice. CRE-LOXP SYSTEM: The bacteriophage-enzyme Cre recognizes loxP-sites in the genome and excises loxP-flanked DNA-regions. Using this system loxP-sites can be introduced into intron regions of a target gene and mice can be created carrying this functional, but loxP-marked gene. When crossed with transgenic mice expressing the Cre-recombinase under control of a tissue-specific and/or inducible promoter the gene will be inactivated in vivo in a timely and regionally controlled fashion.

Entities:  

Mesh:

Year:  1999        PMID: 10554515     DOI: 10.1007/bf03044954

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  15 in total

1.  Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

Authors:  R N Kulkarni; J C Brüning; J N Winnay; C Postic; M A Magnuson; C R Kahn
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

2.  In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

Authors:  K P Lam; R Kühn; K Rajewsky
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

Review 3.  [The knockout mouse--a revolutionizing model in biomedical research].

Authors:  M Mannstadt
Journal:  Med Klin (Munich)       Date:  1997-09-15

4.  Regulation of Cre recombinase activity by the synthetic steroid RU 486.

Authors:  C Kellendonk; F Tronche; A P Monaghan; P O Angrand; F Stewart; G Schütz
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

5.  Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.

Authors:  B Sauer; N Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

Authors:  F Schwenk; U Baron; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

7.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene.

Authors:  D Accili; J Drago; E J Lee; M D Johnson; M H Cool; P Salvatore; L D Asico; P A José; S I Taylor; H Westphal
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

8.  Inducible gene targeting in mice.

Authors:  R Kühn; F Schwenk; M Aguet; K Rajewsky
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

9.  Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system.

Authors:  L Hennighausen; R J Wall; U Tillmann; M Li; P A Furth
Journal:  J Cell Biochem       Date:  1995-12       Impact factor: 4.429

10.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.